“Vault Safety beats a lot of the competition by a long shot. It’s intuitive and easy to use, and having first-hand access to our safety data is irreplaceable.” - Hanssar Chacon, Sr. Director, Global PV and Risk Management, CRISPR Therapeutics

Hear why an emerging biotech company invested with Vault Safety before commercialization. This helped them to anticipate their pharmacovigilance needs and have essential data at hand rather than relying on an outsourced solution.

More Customer Stories

Real-Time Regulatory Data Access for Safety Teams
Promoting Data Access
Simplifying Pharmacovigilance Processes with Vault Safety
How They've Improved
Whose Data is it Anyway? Ensuring Direct Control Over Safety Data and Operations When Outsourcing
Learn More in the Blog

Interested in learning more about Veeva?